IRVINE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development ...

Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results ...

Cargo was founded by two highly acclaimed cell-therapy researchers. The company raised over $500 million to develop ...

Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel therapies that address emerging targets in oncology, today announced it will present preclinical ...

Prime Medicine and Beam Therapeutics had common origins in gene editing. Now they're both pursuing treatments for the same ...

Proscia sells digital pathology software and artificial intelligence tools to pharmaceutical companies and diagnostic ...

(Tune Photo) — Tune Therapeutics named Dr. John McHutchison ... years and prior to IonQ was director of engineering at Amazon Prime. — Shiftboard, a Seattle company providing workforce ...

A privately held company, Tenpoint Therapeutics is backed by AdBio Partners, AlbionVC, British Patient Capital, Eight Roads, EQT Life Sciences, F-Prime Capital, Hillhouse Capital Management ...

Learn more about whether Kymera Therapeutics, Inc. or Ultragenyx Pharmaceutical Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

She speaks compellingly about her patients who, often in the prime of their lives, receive a devastating diagnosis of synovial sarcoma or myxoid liposarcoma and have limited treatment options.